Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Prognostic Factors in an Exercised Model of Chemically-induced Mammary Cancer

ANTONIETA ALVARADO, ANA I. FAUSTINO-ROCHA, RITA FERREIRA, RAFAEL MENDES, JOSÉ ALBERTO DUARTE, MARIA JOÃO PIRES, BRUNO COLAÇO and PAULA A. OLIVEIRA
Anticancer Research May 2016, 36 (5) 2181-2188;
ANTONIETA ALVARADO
1Área de Patología, Decanato de Ciencias Veterinarias, Universidad Centroccidental “Lisandro Alvarado”, UCLA, Lara, Venezuela
2Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, UTAD, Vila Real, Portugal
3Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Vila Real, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANA I. FAUSTINO-ROCHA
2Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, UTAD, Vila Real, Portugal
3Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Vila Real, Portugal
4Organic Chemistry, Natural Products and Foodstuffs (QOPNA), Mass Spectrometry Center, Department of Chemistry, University of Aveiro, Aveiro, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RITA FERREIRA
4Organic Chemistry, Natural Products and Foodstuffs (QOPNA), Mass Spectrometry Center, Department of Chemistry, University of Aveiro, Aveiro, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAFAEL MENDES
5School of Life Sciences and Environment (ECVA), UTAD, Vila Real, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSÉ ALBERTO DUARTE
6Center of Investigation and Physical Activity, Heath and Laser (CIAFEL), Faculty of Sports, University of Porto, Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARIA JOÃO PIRES
2Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, UTAD, Vila Real, Portugal
3Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Vila Real, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRUNO COLAÇO
2Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, UTAD, Vila Real, Portugal
7Department of Zootechnics, School of Agrarian and Veterinary Sciences, UTAD, Vila Real, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAULA A. OLIVEIRA
2Department of Veterinary Sciences, School of Agrarian and Veterinary Sciences, University of Trás-os-Montes and Alto Douro, UTAD, Vila Real, Portugal
3Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), UTAD, Vila Real, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pamo@utad.pt
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Estrogen receptor α (ERα) and Ki-67 are strong prognostic and predictive markers in woman breast cancer. This study aimed to evaluate the immunoexpression of prognostic factor markers ERα, Ki-67 proliferation index (Ki-67 PI) and the mitotic activity index (MAI) in mammary tumors induced by 1-methyl-1-nitrosourea (MNU) in female Sprague-Dawley rats submitted to lifelong exercise training. Materials and Methods: Thirty female rats were injected with MNU and randomly divided into two groups: sedentary and exercised. Results: All neoplasms from both groups were ERα-positive with an H-score ≥20. Statistically significant differences were not found in the ERα H-score, Ki-67 PI and MAI between groups. The absolute value of ERα H-score was higher in the exercised group, while the Ki-67 PI and MAI were higher in the sedentary group. Conclusion: Tumors from the exercised group were less proliferative and more differentiated, suggesting that long-term exercise training had positive effects on mammary carcinogenesis.

  • ERα H-Score
  • Ki-67 proliferation index
  • mitotic index
  • rat
  • 1-methyl-1-nitrosourea

Breast cancer affects approximately one out of ten women in the world and it has been demonstrated that chemically-induced mammary tumors in female rats histopathologically resemble those developed by humans (1). When exposed to the carcinogen agent 1-methyl-1-nitrosourea (MNU), female Sprague-Dawley rats develop a high number of mammary tumors (2-4). Additionally, the mammary tumors induced by this chemical carcinogen behave as hormone-dependent and they are characterized by the expression of estrogen receptors (ERs) (5-8).

ERs are nuclei receptors that regulate cell growth, differentiation and homeostasis. Until now, two ERs isoforms are known: ERα and ERβ. The steroid hormone estradiol, which is necessary for sexual differentiation, fertility and development, acts by binding with these two isoforms (9, 10). The ERα expression is a well-established marker of cell proliferation and its high expression is considered a good prognostic and predictive marker related with increase of survival and delay of tumor recurrence after hormone therapy in human mammary cancer (11, 12).

Another important marker of cellular proliferation in mammary cancer is the protein Ki-67, which is involved in cellular proliferation and expressed in different phases of the cell cycle, such as G1, S, G2 and M, but not in the resting phase G0. Furthermore, the expression of Ki-67 is associated with a ribosomal pathway for RNA transcription (13-15). Although Ki-67 is not included as a routine biological marker, it is recommended as a prognostic and predictive marker in human mammary cancer (15).

Researchers who have conducted studies in this field, using the female Sprague-Dawley rat model of mammary cancer have observed positive effects of physical exercise on these tumors, including the rate of tumors per animal and the type of tumors in terms of their histopathological grade (16-19). This work aimed to evaluate the effects of lifelong exercise training on the immunoexpression of ERα, Ki-67 and the mitotic activity index (MAI) in MNU-induced mammary tumors in female Sprague-Dawley rats.

Materials and Methods

Animals and experimental design. All procedures followed the biosecurity standards specified for the studies using animal models and were approved by Direção Geral de Alimentação e Veterinária (Approval n° 008961). Thirty outbred female Sprague-Dawley rats were divided into two experimental groups as follows: sedentary (n=15) and exercised (n=15). At 50th day of age, all animals received an intraperitoneal injection (50 mg/kg body weight) of the carcinogen agent MNU (ISOPAC®, lot 100 M1436V; Sigma Chemical Co., Madrid, Spain). The day of the carcinogen administration was defined as the first day of the experiment.

A Treadmill Control® LE 8710 (Panlab, Harvard Apparatus; Holliston, MA, USA) was used for the exercise training. Animals were subjected to the exercise training during 35 weeks (60 min/day, at a speed of 20 m/min, 5 days a week with a rest of 2 days). Both mammary gland chains of all animals were weekly palpated.

Sacrifice and necropsy of animals. All animals were sacrificed by exsanguination by cardiac puncture under deep anesthesia (ketamine and xylazine), as indicated by the Federation of European Laboratory Animal Science Associations (20). Mammary tumors were excised and immediately fixed in 10% phosphate buffered-formaldehyde during 24 hours.

Histopathology and immunohistochemistry. The fixated tissues were cut, processed, embedded in paraffin and 2-μm-thick cut sections were stained with hematoxylin and eosin (H&E) for histopathological evaluation by three independent pathologists. The tumors were histologically classified and categorized according to their histogenesis and biological behavior, according to Russo and Russo (21), taking into consideration only the concordance type of lesion or lesions with a high proportion in each tumor section. For immunohistochemistry, the NovolinkTM Polymer Detection System (Leica®, Newcastle, UK) was used according to the instructions provided by the manufacturer. The sections were incubated with the primary antibody for ERα (clone 6F11, mouse monoclonal anti-human; Leica®) at a dilution of 1:50 for one and half hour at room temperature and with the primary antibody for Ki-67 (clone MIB-5, mouse monoclonal anti-rat; DAKO®, Glostrup, Denmark) at a dilution of 1:50, overnight at 4°C. The antigen retrieval was performed with thermic treatment by microwave using 3 cycles for ERα and 4 cycles for Ki-67 of 5 minutes each one in citrate buffer solution. The tissues were counterstained with hematoxylin.

The H-score method was used for assessment of the ERα immunoexpression in a total of 1,000 neoplastic cells producing a score range from 0 to 300, as previously described by Kinsel et al. (12). An H-score of more than 1 was considered as positive. Normal mammary tissue with and without the primary antibody was used as positive and negative control, respectively.

The Ki-67 was scored as the percentage of nuclei-stained cells in a total of 1,000 neoplastic cells, independently of invasiveness of the tumor, using a 40× objective for high power fields (HPF) and denoted as Ki-67 proliferation index (Ki-67 PI). The tumor tissue without the primary antibody was used as negative control and the hair follicles present in the histological cut that looked a correct intensity of nuclear staining were used as positive control.

The MAI was evaluated in 10 HPF of the most proliferative areas of the tumor, i.e. tumor periphery excluding necrosis and apoptosis, using a 40× objective (LEICA DM500 diagnostic microscope, 0.45 mm diameter; Leica®). The MAI was scored taking into account the mitotic figures per microscopic field and denoted as: low (0-6), intermediate (7-14) or high (≥15) (22).

ER H-score, Ki-67 PI and MAI were evaluated by two independent pathologists.

Statistical analysis. Descriptive statistics, such as mean, standard deviation (SD) and proportion in base to percentage were used to express the presence and classification of mammary tumors in both experimental groups. For the comparison between groups, the ANOVA and Tukey-Kramer honestly significant difference (HSD) tests for all pairs were used. The statistical analysis was performed using the JMP starter 5.0.1. program (SAS Institute Inc., Cary, NC, USA). p-Values lower than 0.05 were considered statistically significant.

Results

General findings. Eight animals died during the experiment: four animals from the sedentary group and four from the exercised one. Additionally, one animal from the exercised group did not adapt to the exercise training and was excluded from the experiment. At the end of the experiment, the sedentary group had 11 animals and the exercised group had 10 animals. All animals from both groups, exercised and sedentary, developed mammary tumors (100% of incidence).

Histopathological evaluation of mammary tumors. Considering the predominant histological patterns in each mammary tumor, a total of 32 mammary lesions (all neoplasms) in the exercised group and 37 mammary lesions (neoplasms and preneoplastic lesions) in the sedentary group were identified (Figure 1A and 1B). Papillary carcinoma was the histological pattern most frequently identified in both groups, followed by the cribriform carcinoma pattern.

The grade of malignancy of mammary tumors was higher in sedentary group than in exercised one; the majority of the mammary neoplasms identified in both groups were classified as epithelial malignant lesions (p>0.05) (Figure 1B). Additionally, the animals from sedentary group developed two preneoplastic lesions (intraductal proliferation (IDP)) and two comedo carcinomas that were not found in exercised group (Figures 1A and 2A).

Immunohistochemical evaluation of mammary tumors. All mammary lesions from both groups were ERα-positive with an H-score ≥20. Concerning the ERα H-score in each histological pattern, the papillary pattern in exercised group exhibited the highest mean and fibroadenoma the lowest mean, with these values being statistically different (p<0.05) (Table I). However, the differences of Ki-67 PI among histological patterns did not reach the level of statistical significance (p>0.05). In general, the MAI was low (<5). The comedo carcinoma in the sedentary group was the histological pattern with the highest MAI (5.35±0.64), followed by cribriform carcinoma pattern in the same group; the differences between these two histological patterns were considered statistically significant (p<0.05) (Table I). Statistically significant differences were also found between the comedo carcinoma and the remaining histological patterns from both groups, exercised and sedentary (p<0.05) (Table I).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Histological patterns of mammary tumors. (A) Number and percentage of each histological pattern and (B) histological lesions classified according to their histogenesis in both groups, exercised and sedentary. IDP, Intraductal proliferation.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Comedo carcinoma pattern. (A) H&E staining, atypical mitosis figures; (B) ERα immunoexpression, (C) Ki-67 immunoexpression. Objective 40×.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

ERα H-score, Ki-67 PI and MAI of each histological pattern of rat mammary tumors developed by animals from exercised and sedentary groups. Mean±S.D.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

ERα H-score, Ki-67 PI and MAI in different histological types of rat mammary tumors classified according to their histogenesis and biological behavior in exercised and sedentary groups. Mean±S.D.

In both groups, the highest H-score was identified in epithelial malignant neoplasms with a statistically significant difference between this histological type and epithelial-stromal benign neoplasm from exercised group (p<0.05) (Table II, Figure 2B). Statistically significant differences were not found in Ki-67 PI between groups (p>0.05); the epithelial malignant lesions were the histological type with the highest PI in both groups (Table II, Figure 2C). Statistically significant differences in MAI were not found among the histological types in both groups (p>0.05) and, similarly to the Ki-67 PI, the epithelial malignant lesions were the histological type with the highest MAI (Table II).

Comparison of ERα H-score, Ki-67 PI and MAI between groups. Regardless of the histological type or pattern of the mammary lesions, statistically significant differences were not found in the means of ERα H-score, Ki-67 PI and MAI between groups (p>0.05). However, the absolute mean value of ERα H-score was higher in the exercised group, while the Ki-67 PI and MAI were higher in the sedentary group (Table III).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Means' comparison of ERα H-score, Ki-67 PI and MAI between exercised and sedentary groups. Mean±S.D.

Discussion

The mammary tumors identified in this study were similar to those previously described by Russo and Russo (21) who further reported that the papillary carcinoma is the most typical and frequent pattern observed in MNU-induced mammary tumors. Concerning the effects of exercise training on chemically-induced mammary tumorigenesis, a beneficial effect was observed, i.e. decrease of the number of lesions and their malignancy, which is in accordance with previous reports (17-19).

It has been proved that the semi-quantitative method to quantify the expression of ERα in breast cancer through immunohistochemical markers is especially powerful to predict the response of women's breast cancer to endocrine therapy. The high expression of ER is an indicator of better response to antiestrogen therapy and good prognostic in breast cancer patients; while its low expression indicates the need to apply chemotherapy in addition to endocrine therapy (23). In these results, despite the fact that the number of malignant lesions was higher in sedentary animals, the ERα H-score was higher in the exercised group. Away from the fact that the exercise training did not decrease the expression of ERα, as expected, higher expression of ER in epithelial malignant lesions from exercised group suggests that these animals exhibited more differentiated mammary malignant lesions. This is in accordance with the findings of Qiu et al. (24) and Chan et al. (25) who reported that the rats' chemically-induced mammary carcinomas show papillary and cribriform carcinoma patterns with a greater cellular differentiation and higher ERα positive expression. These data are also in agreement with those described by McCormick et al. (26) and Russo and Russo (6) who reported that high levels of steroid hormones and their precursors can be inhibitors of chemically-induced carcinogenesis in rats by the induction of the differentiation of the mammary parenchyma.

Ki-67 expression has been recently identified as a predictive and prognostic factor in breast cancer. Its high expression is associated with poor prognosis and can be used to monitor the tumors' response to treatment (13, 27-29). In a previous study, it was reported that Sprague-Dawley rats have an elevation of Ki-67 expression in line with an altered ribosomal pathway, which could be related to deregulated protein synthesis machinery and the promotion of malignant tumor progression in this strain (30). In this work, the Ki-67 PI exhibited low values in both groups, exercised and sedentary. According to Yerushalmi et al. (15), Ki-67 PI <14 indicates a low risk of neoplasms' recurrence and a better response to therapy. The lower Ki-67 PI in exercised than in sedentary group is an indicator of better prognosis in exercised animals. These results were different from those observed by Malicka et al. (31) who, in a similar study using an exercised model of chemically-induced mammary cancer in female rats, did not observe any differences in Ki-67 expression. However, these authors did not present the values obtained for the Ki-67 immunoexpression. Westerlind et al. (32) evaluated the expression of proliferating cell nuclear antigen (PCNA) in exercised and sedentary animals under a protocol of chemical carcinogenesis. They observed that the expression of PCNA was higher in exercised animals. These results cannot be compared with ours because PCNA is a less specific marker detecting not only cellular proliferation but also cellular reparation. Additionally, these different results may be due to the different period of exercise training employed between studies (12 weeks in the aforementioned study and 35 weeks in the present work).

Mitotic count is primordial in studying cancer and evaluated histopathologically (33). In the last years, this proliferation index was considered to be a strong prognostic factor in breast cancer and employed as a routine component of histopatological studies with clinical applicability (34). Despite the limitations for their estimation, mainly due to the variability of scoring and the standardization of immunohistochemical diagnosis (35), nowadays, mitotic counts in conjunction with Ki-67 PI are important predictors for mammary cancer. In this study, a low MAI was inclusively obtained in the most aggressive histological pattern, the comedo carcinoma. Despite the fact that the comedo carcinoma is a malignant neoplasia, highly cellular, with a solid and expansive growth, the MNU-induced comedo carcinomas of the present study exhibited low proliferation (MAI was <6 and PI<14).

These results denoted that the MNU-induced mammary tumors have, in general, a low rate of proliferation similar to that reported in human mammary cancer where the ER-positive mammary tumors showed a lower rate of proliferation (lower KI-67 PI and MAI) and better prognosis than the ER-negative ones (34). In relation to the effect of the exercise, a positive effect was observed, since both proliferation indexes were lower in the exercise than in the sedentary group.

In this study, the comparison between ERα H-score, Ki-67 PI and MAI was not statistical significant but, taking into account their mean values, interesting results were observed: (i) ERα H-score was higher in exercised group and (ii) Ki-67 PI and MAI were higher in sedentary group denoting the positive effects of exercise training in the development of mammary cancer in rats, thus suggesting a better response to hormonal therapy on mammary tumorigenesis.

Acknowledgements

This work was supported by European Investment Funds by FEDER/COMPETE/POCI - Operational Competitiveness and Internationalization Program, under Project POCI-01-0145-FEDER-006958 and Portuguese Foundation for Science and Technology (FCT), under the project UID/AGR/04033/2013, the project PTDC/DES/114122/2009 and post-graduation grant SFRH/BD/102099/2014.

Footnotes

  • Conflicts of Interests

    None to declare.

  • Received February 22, 2016.
  • Revision received April 1, 2016.
  • Accepted April 4, 2016.
  • Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Liska J,
    2. Galbavy S,
    3. Macejova D,
    4. Zlatos J,
    5. Brtko J
    : Histopathology of Mammary Tumours in Female Rats Treated with 1-Methyl-1-Nitrosourea. Endocr Regul 34: 91-96, 2000.
    OpenUrlPubMed
  2. ↵
    1. Gal A,
    2. Baba A,
    3. Miclaus V,
    4. Bouari C,
    5. Taulescu M,
    6. Bolfa P,
    7. Borza G,
    8. Catoi C
    : Comparative aspects regarding MNU-induced mammary carcinogenesis in immature Sprague-Dowley and Whistar rats. Bulletin UASVM, Veterinary Medicine 68: 159-163, 2011.
    OpenUrl
    1. Faustino-Rocha AI,
    2. Oliveira PA,
    3. Duarte JA,
    4. Ferreira R,
    5. Ginja M
    : Ultrasonographic evaluation of gastrocnemius muscle in a rat model of N-Methyl-N-nitrosourea-induced mammary Tumor. In Vivo 27: 803-807, 2013.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Faustino-Rocha AI,
    2. Ferreira R,
    3. Oliveira PA,
    4. Gama A,
    5. Ginja M
    : N-Methyl-N-nitrosourea as a mammary carcinogenic agent. Tumor Biol 36: 9095-9117, 2015.
    OpenUrl
  4. ↵
    1. Rudmann D,
    2. Cardiff R,
    3. Chouinard L,
    4. Goodman D,
    5. Kuttler K,
    6. Marxfeld H,
    7. Molinolo A,
    8. Treumann S,
    9. Yoshizawa K
    : Proliferative and nonproliferative lesions of the rat and mouse mammary, zymbal's, preputial, and clitoral glands. Toxicol Pathol 40: 7S-39S, 2012.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Russo IH,
    2. Russo J
    : Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol 3: 49-61, 1998.
    OpenUrlCrossRefPubMed
    1. Thordarson G,
    2. Lee AV,
    3. McCarty M,
    4. Van Horn K,
    5. Chu O,
    6. Chou YC,
    7. Yang J,
    8. Guzman RC,
    9. Nandi S,
    10. Talamantes F
    : Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats. Carcinogenesis 22: 2039-2048, 2001.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Soares-Maia R,
    2. Faustino-Rocha AI,
    3. Teixeira-Guedes CI,
    4. Pinho-Oliveira J,
    5. Talhada D,
    6. Rema A,
    7. Faria F,
    8. Ginja M,
    9. Ferreira R,
    10. da Costa RMG,
    11. Oliveira PA,
    12. Lopes C
    : MNU-Induced Rat Mammary Carcinomas: Immunohistology and Estrogen Receptor Expression. J Environ Pathol Tox Oncol 32: 157-163, 2013.
    OpenUrl
  7. ↵
    1. Hanstein B,
    2. Djahansouzi S,
    3. Dall P,
    4. Beckmann MW,
    5. Bender HG
    : Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol 150: 243-255, 2004.
    OpenUrlAbstract
  8. ↵
    1. Lannigan DA
    : Estrogen receptor phosphorylation. Steroids 68: 1-9, 2003.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hammond MEH,
    2. Hayes DF,
    3. Dowsett M,
    4. Allred DC,
    5. Hagerty KL,
    6. Badve S,
    7. Fitzgibbons PL,
    8. Francis G,
    9. Goldstein NS,
    10. Hayes M,
    11. Hicks DG,
    12. Lester S,
    13. Love R,
    14. Mangu PB,
    15. McShane L,
    16. Miller K,
    17. Osborne CK,
    18. Paik S,
    19. Perlmutter J,
    20. Rhodes A,
    21. Sasano H,
    22. Schwartz JN,
    23. Sweep FCG,
    24. Taube S,
    25. Torlakovic EE,
    26. Valenstein P,
    27. Viale G,
    28. Visscher D,
    29. Wheeler T,
    30. Williams RB,
    31. Wittliff JL,
    32. Wolff AC
    : American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. J Clin Oncol 28: 2784-2795, 2010.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Kinsel LB,
    2. Szabo E,
    3. Greene GL,
    4. Konrath J,
    5. Leight GS,
    6. Mccarty KS
    : Immunocytochemical analysis of estrogen-receptors as a predictor of prognosis in breast-cancer patients - comparison with quantitative biochemical methods. Cancer Res 49: 1052-1056, 1989.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Mrklic I,
    2. Capkun V,
    3. Pogorelic Z,
    4. Tomic S
    : Prognostic value of Ki-67 proliferating index in triple negative breast carcinomas. Pathol Res Pract 209: 296-301, 2013.
    OpenUrlPubMed
    1. Scholzen T,
    2. Gerdes J
    : The Ki-67 protein: From the known and the unknown. J Cell Physiol 182: 311-322, 2000.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Yerushalmi R,
    2. Woods R,
    3. Ravdin PM,
    4. Hayes MM,
    5. Gelmon KA
    : Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol 11: 174-183, 2010.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Thompson HJ
    : Effect of exercise intensity and duration on the induction of mammary carcinogenesis. Cancer Res 54: S1960-S1963, 1994.
    OpenUrl
  14. ↵
    1. Thompson HJ
    : Effects of physical activity and exercise on experimentally-induced mammary carcinogenesis. Breast Cancer Res Tr 46: 135-141, 1997.
    OpenUrl
    1. Thompson HJ,
    2. Wolfe P,
    3. McTiernan A,
    4. Jiang WQ,
    5. Zhu ZJ
    : Wheel Running-Induced Changes in Plasma Biomarkers and Carcinogenic Response in the 1-Methyl-1-Nitrosourea-Induced Rat Model for Breast Cancer. Cancer Prev Res 3: 1484-1492, 2010.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Whittal-Strange KS,
    2. Chadau S,
    3. Parkhouse WS
    : Exercise during puberty and NMU induced mammary tumorigenesis in rats. Breast Cancer Res Tr 47: 1-8, 1998.
    OpenUrl
  16. ↵
    1. Forbes D,
    2. Blom H,
    3. Kostomitsopoulos N,
    4. Moore G,
    5. Perretta G
    : Felasa Euroguide on the accommodation and care of animals used for experimental and other scientific purposes. London, Royal Society of Medicine, 2007.
  17. ↵
    1. Russo J,
    2. Russo IH
    : Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol 5: 187-200, 2000.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Lehr HA,
    2. Rochat C,
    3. Schaper C,
    4. Nobile A,
    5. Shanouda S,
    6. Vijgen S,
    7. Gauthier A,
    8. Obermann E,
    9. Leuba S,
    10. Schmidt M,
    11. Ruegg CC,
    12. Delaloye JF,
    13. Simiantonaki N,
    14. Schaefer SC
    : Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas. Modern Pathol 26: 336-342, 2013.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Morgan DAL,
    2. Refalo NA,
    3. Cheung KL
    : Strength of ER-positivity in relation to survival in ER-positive breast cancer treated by adjuvant tamoxifen as sole systemic therapy. Breast 20: 215-219, 2011.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Qiu CP,
    2. Shan L,
    3. Yu MS,
    4. Snyderwine EG
    : Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Carcinogenesis 26: 763-769, 2005.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Chan MM,
    2. Lu X,
    3. Merchant FM,
    4. Iglehart JD,
    5. Miron PL
    : Serial transplantation of NMU-induced rat mammary tumors: A model of human breast cancer progression. Int J Cancer 121: 474-485, 2007.
    OpenUrlPubMed
  22. ↵
    1. McCormick DL,
    2. Rao KVN,
    3. Johnson WD,
    4. BowmanGram TA,
    5. Steele VE,
    6. Lubet RA,
    7. Kelloff GJ
    : Exceptional chemo-preventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res 56: 1724-1726, 1996.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Tan QX,
    2. Qin QH,
    3. Yang WP,
    4. Mo QG,
    5. Wei CY
    : Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. Int J Clin Exp Pathol 7: 6862-6870, 2014.
    OpenUrlPubMed
    1. Wishart GC,
    2. Rakha E,
    3. Green A,
    4. Ellis I,
    5. Ali HR,
    6. Provenzano E,
    7. Blows FM,
    8. Caldas C,
    9. Pharoah PDP
    : Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer. Bmc Cancer 14: 2014.
  24. ↵
    1. Yuan JP,
    2. Wang LW,
    3. Qu AP,
    4. Chen JM,
    5. Xiang QM,
    6. Chen C,
    7. Sun SR,
    8. Pang DW,
    9. Liu J,
    10. Li Y
    : Quantum Dots-Based Quantitative and In Situ Multiple Imaging on Ki67 and Cytokeratin to Improve Ki67 Assessment in Breast Cancer. Plos One 10: 2015.
  25. ↵
    1. Luzhna L,
    2. Kutanzi K,
    3. Kovalchuk O
    : Gene expression and epigenetic profiles of mammary gland tissue: Insight into the differential predisposition of four rat strains to mammary gland cancer. Mutat Res-Gen Tox En 779: 39-56, 2015.
    OpenUrl
  26. ↵
    1. Malicka I,
    2. Siewierska K,
    3. Pula B,
    4. Kobierzycki C,
    5. Haus D,
    6. Cegielski M,
    7. Dziegiel P,
    8. Podhorska-Okolow M,
    9. Wozniewski M
    : The Effect of Physical Training on the N-methyl-N-nitrosourea Induced Mammary Carcinogenesis of Sprague–Dawley Rats. Exp Biol Med 0: 1-8, 2015.
  27. ↵
    1. Westerlind KC,
    2. McCarty HL,
    3. Gibson KJ,
    4. Strange R
    : Effect of exercise on the rat mammary gland: implications for carcinogenesis. Acta Physiol Scand 175: 147-156, 2002.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Elston CW,
    2. Ellis IO
    : Pathological Prognostic Factors in Breast-Cancer .1. the Value of Histological Grade in Breast-Cancer - Experience from A Large Study with Long-Term Follow-Up. Histopathology 19: 403-410, 1991.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Klintman M,
    2. Strand C,
    3. Ahlin C,
    4. Beglerbegovic S,
    5. Fjallskog ML,
    6. Grabau D,
    7. Gudlaugsson E,
    8. Janssen EAM,
    9. Lovgren K,
    10. Skaland I,
    11. Bendahl PO,
    12. Malmstrom P,
    13. Baak JPA,
    14. Ferno M
    : The prognostic value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer. Plos One 8: 2013.
  30. ↵
    1. Bertucci F,
    2. Finetti P,
    3. Roche H,
    4. Le Doussal JM,
    5. Marisa L,
    6. Martin AL,
    7. Lacroix-Triki M,
    8. Blanc-Fournier C,
    9. Jacquemier J,
    10. Peyro-Saint-Paul H,
    11. Viens P,
    12. Sotiriou C,
    13. Birnbaum D,
    14. Penault-Llorca F
    : Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients. Ann Oncol 24: 625-632, 2013.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research: 36 (5)
Anticancer Research
Vol. 36, Issue 5
May 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognostic Factors in an Exercised Model of Chemically-induced Mammary Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognostic Factors in an Exercised Model of Chemically-induced Mammary Cancer
ANTONIETA ALVARADO, ANA I. FAUSTINO-ROCHA, RITA FERREIRA, RAFAEL MENDES, JOSÉ ALBERTO DUARTE, MARIA JOÃO PIRES, BRUNO COLAÇO, PAULA A. OLIVEIRA
Anticancer Research May 2016, 36 (5) 2181-2188;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognostic Factors in an Exercised Model of Chemically-induced Mammary Cancer
ANTONIETA ALVARADO, ANA I. FAUSTINO-ROCHA, RITA FERREIRA, RAFAEL MENDES, JOSÉ ALBERTO DUARTE, MARIA JOÃO PIRES, BRUNO COLAÇO, PAULA A. OLIVEIRA
Anticancer Research May 2016, 36 (5) 2181-2188;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Impact of Exercise Training on Breast Cancer
  • Impact of Physical Training on Sex Hormones and Their Receptors During N-Methyl-N-nitrosourea-induced Carcinogenesis in Rats
  • Google Scholar

More in this TOC Section

  • Docosahexaenoic Acid Potentiates the Anticancer Effect of the Menadione/Ascorbate Redox Couple by Increasing Mitochondrial Superoxide and Accelerating ATP Depletion
  • Streptonigrin Mitigates Lung Cancer-induced Cachexia by Suppressing TCF4/TWIST1-induced PTHLH Expression
  • Atezolizumab Retains Cellular Binding to Programmed Death Ligand 1 Following Aerosolization via Mesh Nebulizer
Show more Experimental Studies

Similar Articles

Keywords

  • ERα H-Score
  • Ki-67 proliferation index
  • mitotic index
  • rat
  • 1-methyl-1-nitrosourea
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire